Stocks and Investing Stocks and Investing
Tue, November 23, 2021

Mani Foroohar Maintained (ARWR) at Hold with Increased Target to $45 on, Nov 23rd, 2021


Published on 2024-10-27 18:45:22 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $44 to $45 on, Nov 23rd, 2021.

Mani has made no other calls on ARWR in the last 4 months.



There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 0 agree with Mani's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mani


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $100 on, Tuesday, August 10th, 2021
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $94 on, Friday, August 6th, 2021
Contributing Sources